Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

BioRestorative Therapies (BRTX) Return on Capital Employed (2016 - 2025)

BioRestorative Therapies (BRTX) has disclosed Return on Capital Employed for 15 consecutive years, with 3.98% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Capital Employed fell 286.0% year-over-year to 3.98%, compared with a TTM value of 3.98% through Sep 2025, down 286.0%, and an annual FY2024 reading of 1.33%, down 5.0% over the prior year.
  • Return on Capital Employed was 3.98% for Q3 2025 at BioRestorative Therapies, down from 2.28% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 1.1% in Q2 2024 and bottomed at 13.98% in Q3 2021.
  • Average Return on Capital Employed over 5 years is 3.35%, with a median of 1.72% recorded in 2025.
  • Peak annual rise in Return on Capital Employed hit 1363bps in 2021, while the deepest fall reached -662bps in 2021.
  • Year by year, Return on Capital Employed stood at 2.2% in 2021, then increased by 23bps to 1.69% in 2022, then increased by 15bps to 1.44% in 2023, then increased by 17bps to 1.19% in 2024, then tumbled by -234bps to 3.98% in 2025.
  • Business Quant data shows Return on Capital Employed for BRTX at 3.98% in Q3 2025, 2.28% in Q2 2025, and 1.72% in Q1 2025.